An An Intriguing Case of Rapidly Progressive Renal Failure in an Acquired Immunodeficiency Syndrome Patient

Main Article Content

Pulak Azad
Lakshmikant Jha
Pranav Tyagi

Abstract

Rapidly progressive renal failure in a patient living with human immunodeficiency virus is a curious scenario that encompasses differentials such as thrombotic microangiopathy, Immune reconstitution inflammatory syndrome, acute interstitial nephritis, and acute tubular necrosis. A 36-year-old male patient was admitted with fever and weakness for 2 months. He was detected to have pulmonary Koch’s and Human immunodeficiency virus positive. He was initiated on anti-tubercular regiemn followed by highly active anti-retroviral therapy. Patient also had decreased urine output since past 3 weeks. He had baseline creatinine of 1 which increased to 2.1 in 1st week, 3.2 in 2nd week and had progressive derangement in KFT for 5.1 in 3rd week. He was admitted in the 4th week when his serum creatinine was 6.9. As it further rose to 8.1 along with decreased urine output biopsy was planned in view of rapidly progressive renal failure and the patient was initiated on hemodialysis. Biopsy was suggestive of non-necrotizing granulomatous interstitial nephritis and glomeruli showed non – proliferative morphology. After highly active anti-retroviral therapy modification and steroid addition serum creatinine started coming down and patient became dialysis independent.

Article Details

Azad, P., Jha, L., & Tyagi, P. (2025). An An Intriguing Case of Rapidly Progressive Renal Failure in an Acquired Immunodeficiency Syndrome Patient. Journal of Clinical Nephrology, 9(11), 107–109. https://doi.org/10.29328/journal.jcn.1001167
Case Reports

Copyright (c) 2025 Azad P, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Lakshmikant Jha, Senior Consultant and Director, Nephrology, Dharmashilla Narayana Superspeciality Hospital, Delhi, India

SENIOR CONSULTANT NEPHROLOGY

Pranav Tyagi, Associate Consultant, Nephrology, Dharmashilla Narayana Superspeciality Hospital, Delhi, India

ASSOCIATE CONSULTANT

Ross MJ. Advances in the pathogenesis of HIV-associated kidney diseases. Kidney Int. 2014;86(2):266–274. Available from: https://pubmed.ncbi.nlm.nih.gov/24827777/

McLaughlin MM, Guerrero AJ, Merker A. Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV. Drugs Context. 2018;7:212519. Available from: https://pubmed.ncbi.nlm.nih.gov/29623097/

Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, et al. Immune reconstitution inflammatory syndrome associated with HIV infection: risk factors, pathogenesis and management. Lancet Infect Dis. 2008;8(8):516–523. Available from: https://pubmed.ncbi.nlm.nih.gov/18652998/

Haas M, Kaul S, Eustace JA. HIV-associated immune complex glomerulonephritis with lupus-like features: a clinicopathologic study of 14 cases. Clin J Am Soc Nephrol. 2009;4(8):1301–1307. Available from: https://pubmed.ncbi.nlm.nih.gov/15780090/

Perazella MA. Drug-induced acute interstitial nephritis: the tip of the iceberg. Nat Rev Nephrol. 2010;6(8):461-70. Available from: https://doi.org/10.1038/nrneph.2010.71

Cahn P, Pozniak AL, Mingrone H. Dolutegravir versus efavirenz in antiretroviral-naïve adults with HIV-1 infection. Lancet. 2013;382(9893):700–708.

Wyatt CM. Kidney disease and HIV infection. Top Antivir Med. 2017;25(1):13–16. Available from: https://pubmed.ncbi.nlm.nih.gov/28402929/

Gupta SK. Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system. AIDS. 2008;22(2):99-103. Available from: https://doi.org/10.1089/apc.2007.0052

Hall AM, Hendry BM, Nitsch D, Connolly JO. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Kidney Int. 2011;79(8):825–832. Available from: https://pubmed.ncbi.nlm.nih.gov/21412255/

Muriithi AK, Leung N, Valeri AM. Biopsy-proven granulomatous interstitial nephritis: clinical characteristics and outcomes. Kidney Int. 2012;82(7):797–803.

D’Agati VD, Appel GB. HIV infection and the kidney. J Am Soc Nephrol. 1997;8(1):138–152. Available from: https://doi.org/10.1681/asn.v81138

Wearne N, Swanepoel CR, Boulle A. HIV-associated renal disease in Africa—a changing landscape. Nat Rev Nephrol. 2012;8(4):189–199.

Clarkson MR, Giblin L, O’Connell FP, O’Kelly P, Walshe JJ, Conlon PJ, et al. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Kidney Int. 2004;66(3):1078–1083. Available from: https://doi.org/10.1093/ndt/gfh485

Atta MG, Fine DM. HIV-associated nephropathy and the evolving role of antiretroviral therapy. Clin Infect Dis. 2016;63(3):332–339.